Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octenidine for Prevention of Catheter-Associated Infections
NCT00515151Phase 4Completed
- Sponsor
- University Hospital Freiburg
- Start
- May 2002
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 2
01
Overview
A Phase 4 trial of octenidine in catheter-associated urinary tract infection (CAUTI), Bacteremia, sponsored by University Hospital Freiburg. Started May 2002; status: completed.
02
Drugs
octenidine
03
Conditions
catheter-associated urinary tract infection (CAUTI)Bacteremia
Beyond the preview
Go deeper on NCT00515151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515151.